Oramed Pharmaceuticals Inc (ORMP) — Financial Flexibility Index
Oramed Pharmaceuticals Inc (ORMP) has a Financial Flexibility Index of -0.10x as of March 2026. Free cash flow of $-2.91 Million (operating CF $-2.92 Million minus capex $5.00K) represents 0% of total liabilities ($30.57 Million). Check ORMP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oramed Pharmaceuticals Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Oramed Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Oramed Pharmaceuticals Inc.
Annual Financial Flexibility Index for Oramed Pharmaceuticals Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Oramed Pharmaceuticals Inc. Explore cash flow to debt ratio of Oramed Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-7.21 Million | $-9.14 Million | $31.12 Million | ▲ +72.6% |
| 2024 | -0.85x | $-8.39 Million | $-8.41 Million | $9.93 Million | ▼ -385.4% |
| 2023 | -0.17x | $-10.04 Million | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.69x | $-28.21 Million | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.81x | $-20.81 Million | $-21.18 Million | $11.48 Million | ▼ -72.3% |
| 2020 | -1.05x | $-12.36 Million | $-12.44 Million | $11.75 Million | ▼ -24.2% |
| 2019 | -0.85x | $-12.93 Million | $-12.94 Million | $15.27 Million | ▲ +5.9% |
| 2018 | -0.90x | $-14.65 Million | $-14.66 Million | $16.29 Million | ▼ -200.8% |
| 2017 | -0.30x | $-5.82 Million | $-5.83 Million | $19.47 Million | ▼ -206.7% |
| 2016 | 0.28x | $4.66 Million | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $-4.95 Million | $1.53 Million | ▲ +19.3% |
| 2014 | -4.02x | $-4.05 Million | $-4.07 Million | $1.01 Million | ▲ +37.2% |
| 2013 | -6.40x | $-3.39 Million | $-3.40 Million | $529.41K | ▼ -322.3% |
| 2012 | -1.52x | $-2.30 Million | $-2.30 Million | $1.52 Million | ▲ +45.1% |
| 2011 | -2.76x | $-1.66 Million | $-1.67 Million | $602.02K | — |
| 2010 | 0.00x | $0.00 | $-1.42 Million | $620.62K | ▲ +100.0% |
| 2009 | -4.35x | $-2.25 Million | $-2.25 Million | $515.66K | ▼ -130.7% |
| 2008 | -1.89x | $-1.72 Million | $-1.84 Million | $913.95K | ▼ -341.3% |
| 2007 | -0.43x | $-609.00K | $-611.00K | $1.42 Million | ▲ +28.0% |
| 2006 | -0.59x | $-361.61K | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.43K | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $-40.00K | $10.00K | — |